Sign In

Hadrien Bouchez

Biotech Venture Capital

Hadrien Bouchez is a prominent figure in the venture capital field, currently serving as a Partner at Kurma Partners, a leading European venture capital firm specializing in life sciences. His career at Kurma Partners began in 2014 when he joined as an Analyst. He was promoted to Associate in 2017 and recently elevated to Partner, recognizing his significant contributions to the firm’s growth and investment strategy.15

Educational Background

Hadrien holds a PharmD from the Faculty of Pharmacy in Lille, France, which provides him with a strong foundation in pharmaceutical sciences. Additionally, he earned a Master in Entrepreneurship from ESSEC Business School, equipping him with essential skills for navigating the business aspects of the life sciences sector.1

Professional Achievements

During his tenure at Kurma Partners, Hadrien has been involved in numerous investments through the Kurma Biofund II and III funds. He played a key role in the establishment of several portfolio companies, including:

  • Dynacure
  • Imcheck Therapeutics
  • Flamingo Therapeutics
  • Ermium Therapeutics
  • Corlieve Therapeutics.12

His investment focus typically ranges from $100K to $5.0M, with a sweet spot around $1.5M, particularly in biotech sectors.24

Current Role

As a Partner, Hadrien Bouchez continues to shape the investment landscape at Kurma Partners, contributing to its mission of supporting medical innovation and entrepreneurship within the life sciences industry.53

Highlights

Mar 14 · linkedin

Great news for Kurma Partners portfolio company Amolyt Pharma! We are excited that AstraZeneca will deploy its resources to accelerate the development of AZP-3601. Congrats Thierry Abribat, Thierry Laugel and whole Amolyt team!

Sep 7 · linkedin

Very happy to share the EUR 65 million Series A financing of our portfolio company Corteria Pharmaceuticals, yet another testament to the validity of Kurma Partners very own model of company creation.

Congratulations to the Corteria Pharmaceuticals team and a warm welcome to our new investors Jeito and Orbimed!

#biotechnology #venturecapital #cardiology

Related Questions

What are some of the key companies Hadrien Bouchez has invested in at Kurma Partners?
How did Hadrien Bouchez's background in pharmacy influence his investment strategy?
What is Hadrien Bouchez's role in the Kurma Biofund II and III?
How has Hadrien Bouchez contributed to the growth of Kurma Partners?
What are Hadrien Bouchez's main responsibilities as a Principal at Kurma Partners?
Hadrien Bouchez
Hadrien Bouchez, photo 1
Hadrien Bouchez, photo 2
Add to my network

Location

Amsterdam, North Holland, Netherlands